Answers are grounded in this paper and cite their sources.
The evolution of silicon quantum dots (Si-QDs) embedded in a-SiOx matrix has been controlled by varying the RF power in the He-diluted SiH4 plasma at a low substrate temperature of 300 °C in PECVD. By optimizing the plasma parameters, Si-QDs of very small size, down to ∼2 nm in diameter, with extremely narrow size dispersion at FWHM ∼1 nm and a very high density of ∼2 × 1012 cm−2 has been obtained. The effect of applied RF power controlling the growth mechanism of Si-QDs has been explained by using probable plasma chemistry of SiH4 in He, inside the plasma. Si-QDs with such low dimension and with high density, embedded in a-SiOx matrix, are being reported for the first time. SiOx is the most preferred dielectric medium in device fabrication. This finding by direct plasma synthesis at low substrate temperature may provide strong impetus to the further development of optoelectronic and photonic devices based on Si-QDs.
No takes yet. Share an insight, caveat, or question.
Samanta et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: